166 related articles for article (PubMed ID: 36064683)
1. Skin autofluorescence of Advanced Glycation End-products and mortality in older adults: The roles of chronic kidney disease and diabetes.
Majchrzak C; Cougnard-Gregoire A; Le-Goff M; Féart C; Delcourt C; Reydit M; Helmer C; Rigalleau V
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2526-2533. PubMed ID: 36064683
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
[TBL] [Abstract][Full Text] [Related]
3. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
[TBL] [Abstract][Full Text] [Related]
4. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
5. The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.
Shardlow A; McIntyre NJ; Kolhe NV; Nellums LB; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2020 Jul; 17(7):e1003163. PubMed ID: 32658890
[TBL] [Abstract][Full Text] [Related]
6. Skin autofluorescence and malnutrition as predictors of mortality in persons receiving dialysis: a prospective cohort study.
Viramontes Hörner D; Selby NM; Taal MW
J Hum Nutr Diet; 2020 Dec; 33(6):852-861. PubMed ID: 32383489
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study.
Chen J; Arshi B; Waqas K; Lu T; Bos D; Ikram MA; Uitterlinden AG; Kavousi M; Zillikens MC
Cardiovasc Diabetol; 2023 Nov; 22(1):326. PubMed ID: 38017418
[TBL] [Abstract][Full Text] [Related]
9. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
[TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence and all-cause mortality in stage 3 CKD.
Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1361-8. PubMed ID: 24875193
[TBL] [Abstract][Full Text] [Related]
11. Role of skin autofluorescence in managing renal and cardiac diseases in outpatient dermatology.
Etaee F; Naguib T; Goldust M; Daveluy S; Maibach H
Skin Res Technol; 2022 Nov; 28(6):889-905. PubMed ID: 36305176
[TBL] [Abstract][Full Text] [Related]
12. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
[TBL] [Abstract][Full Text] [Related]
13. A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort).
van de Zande SC; de Vries JK; van den Akker-Scheek I; Zwerver J; Smit AJ
J Sport Health Sci; 2022 Mar; 11(2):260-265. PubMed ID: 32987221
[TBL] [Abstract][Full Text] [Related]
14. Is the measurement of tissue advanced glycosylation products by skin autofluorescence associated with mortality in patients treated by peritoneal dialysis?
Vareesangthip K; Fan S; Davenport A
J Nephrol; 2023 Jan; 36(1):217-224. PubMed ID: 35980536
[TBL] [Abstract][Full Text] [Related]
15. Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: A prospective cohort study from the Hong Kong diabetes biobank.
Jin Q; Lau ES; Luk AO; Ozaki R; Chow EY; So T; Yeung T; Loo KM; Lim CK; Kong AP; ; So WY; Jenkins AJ; Chan JC; Ma RC
Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):436-446. PubMed ID: 34895800
[TBL] [Abstract][Full Text] [Related]
16. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
[TBL] [Abstract][Full Text] [Related]
17. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
[TBL] [Abstract][Full Text] [Related]
18. A new gender-specific model for skin autofluorescence risk stratification.
Ahmad MS; Damanhouri ZA; Kimhofer T; Mosli HH; Holmes E
Sci Rep; 2015 May; 5():10198. PubMed ID: 25974028
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
[TBL] [Abstract][Full Text] [Related]
20. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study.
Waqas K; Chen J; Koromani F; Trajanoska K; van der Eerden BC; Uitterlinden AG; Rivadeneira F; Zillikens MC
J Bone Miner Res; 2020 Oct; 35(10):1904-1913. PubMed ID: 32463533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
